BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
2.260
+0.125 (5.85%)
At close: Nov 22, 2024, 4:00 PM
2.300
+0.040 (1.77%)
After-hours: Nov 22, 2024, 5:26 PM EST
BioCardia Employees
As of December 31, 2023, BioCardia had 20 total employees, including 16 full-time and 4 part-time employees. The number of employees decreased by 16 or -44.44% compared to the previous year.
Employees
20
Change (1Y)
-16
Growth (1Y)
-44.44%
Revenue / Employee
$3,550
Profits / Employee
-$386,100
Market Cap
7.91M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ATI Physical Therapy | 6,000 |
XWELL | 337 |
Ontrak | 104 |
IM Cannabis | 95 |
Syros Pharmaceuticals | 68 |
Applied DNA Sciences | 55 |
Moleculin Biotech | 18 |
Soligenix | 15 |
BCDA News
- 9 days ago - BioCardia, Inc. (BCDA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - BioCardia Regains Full Compliance with Nasdaq Listing Requirements - GlobeNewsWire
- 2 months ago - BioCardia Announces Closing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 3 months ago - BioCardia Announces FDA Market Clearance of Morph® DNA™ Steerable Introducer Product Family - GlobeNewsWire
- 3 months ago - FDA Approves CardiAMP® Heart Failure II Protocol Amendment to Use Proprietary Cell Population Analysis Screening to Define Treatment - GlobeNewsWire
- 3 months ago - BioCardia, Inc. (BCDA) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - BioCardia Reports Second Quarter 2024 Business Highlights and Financial Results - GlobeNewsWire
- 4 months ago - BioCardia Announces United States Patent Issuance on Morph DNA Multi-Directional Steerable Catheter Transseptal Application - GlobeNewsWire